AVROBIO Inc

For the period ended Mar 31, 2024. Filed May 9, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

TECX$20.64+6.3%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Balance Sheets

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

	March 31,2024	December 31,2023
Assets
Current assets:
Cash and cash equivalents	$90,481	$98,020
Restricted cash	283	283
Prepaid expenses and other current assets	1,074	1,958
Total current assets	91,838	100,261
Operating lease assets	110	432
Restricted cash, net of current portion	400	400
Total assets	$92,348	$101,093
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$243	$27
Accrued expenses and other current liabilities	3,042	5,449
Operating lease liabilities	224	878
Total current liabilities	3,509	6,354
Total liabilities	3,509	6,354
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized and no shares issued or outstanding as of March 31, 2024 and December 31, 2023	—	—
Common stock, $0.0001 par value; 150,000 shares authorized; 44,882 and 44,654 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	4	4
Additional paid-in capital	572,918	572,010
Accumulated deficit	(484,083)	(477,275)
Total stockholders’ equity	88,839	94,739
Total liabilities and stockholders’ equity	$92,348	$101,093

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.